NeoStem Receives Drug Manufacture License for Irvine Facility

2015-01-20T15:42:08-08:00

NeoStem Receives Drug Manufacture License for Irvine FacilityLicense Allows Manufacture and Distribution of Eltrapuldencel-T (NBS20) for Clinical Trial UseNEW YORK, Jan. 20, 2015 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NBS) a ...